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A GROWTH promoting substance has recently been isolated from animal
tissues and egg-yolks which markedly enhances the growth of transplantable
tumours by stimulating the biosynthesis of proteins (Hradec, 1958a). Some
chemical as well as biological properties of this factor indicate its possible relation
to an endogenous carcinogenic substance (Kleinenberg, Neufach, and Shabad,
1941). For this reason it was necessary to evaluate the possible effect of chemical
carcinogens on the growth rate of experimental tumours.
On the basis of some older papers a general growth promoting activity of
carcinogenic hydrobarbons can be assumed. Enhanced growth was observed in
plants when higher doses of 3,4-benzpyrene were added (Rarei and Gummel,
1938) the same being true for regeneration in worms when the same substance or
20-methylcholanthrene was used (Owen, Weiss, and Prince, 1939). Similar effects
were shown when these substances were tested in tissue cultures. Very small
doses of carcinogenic hydrocarbons exhibited a stimulating effect on the culture
growth while higher doses led to an inhibition of this process (Creech, 1940).
On the other hand, an inihibitory effect of 3,4-benzopyrene on the growth of a
transplantable tumour in rats was established when this substance was given in
daily injections to tumour-bearing animals (Haddow, 1935). This effect was
claimed to be specific for various carcinogenic substances while the majority of
non-carcinogenic compounds were without effect (Euler and Skarzynski, 1942).
No definite conclusions can therefore be drawn from these experiments, some
of them showing an enhancing effect of carcinogenic substances on the tissue
growth while others on the contrary demonstrating an inhibitory activity of these
substances. It seems probable that the choice of diverse experimental techniques
as well as doses of substances used in these experiments may be responsible for
these conflicting results.
We thought it necessary therefore to test the effect of a wide range of doses
of carcinogenic substances as well as of some chemically related non-carcinogenic
compounds on the growth rate of Ehrlich ascites carcinoma in mice. When trying
to explain the possible mechanism of the stimulating activity of some of these
substances the probable effect on the biosynthesis of proteins could not be ex-
cluded. It is a well established fact that some substances affecting the growth of
experimental tumours also have a marked effect on the incorporation of labelled
amino acids into proteins. This is true for instance for sarcomycin (Quastel, 1958).
No experiments have so far been reported on the effect ofpolycyclic hydrocarbonsGROWTH OF EHRLICH ASCITES CARCINOMA
and related compounds on the incorporation of labelled amino acids into proteins.
Evidence is presented that the stimulatory effect on the biosynthesis of proteins
promoted by these substances may be related to the enhanced tumour growth and
that this effect should not be omitted when attempts are made to explain the
mode of action of chemical carcinogens.
MATERIALS AND METHODS
Experimnental animals
White albino mice of mixed stock or inbred rats of the Wistar strain were
used throughout our experiments. Animals weighing 20-25 g. and 180-200 g..
respectively, of both sexes, housed in glass cages, were fed Larsen diet and given
water ad libitum.
In vivo procedures
Each dose of substance tested was usually administered to a group of 30 mice.
One experimental series, used for testing the effect of one particular substance in
differenit amounts, consisted of 6-10 such groups together with one control group.
Compounds used in these experiments, i.e. 3,4-benzopyrene, 1,2,5,6-dibenz-
anithracene, anthracene, phenanthrene, chrysene, cholesterol, and dehydrocholic
acid, were all of C.P. grade and no further purification of them was performed.
For administration to animals they were finely homogenized in olive oil in a glass
homogenizer and administered in one subcutaneous injection (0'1 ml.) on the day
preceding the inoculation of Ehrlich ascites carcinoma. Pure olive oil was
administered in the same way to control animals.
Ehrlich ascites carcinoma was maintained in the same stock of mice. For the
purposes of transplantation, 5-10 tumour-bearing animals were sacrificed, ascites
drawn, pooled, diluted with saline to contain 3-5 x 106 cells in 0'1 ml., and
administered intraperitoneally, 0-1 ml. each, to all mice of one experimental series.
No attempts were made to give exactly the same number of tumour cells to
different experimental series since control groups were included in all of them.
The number of dead mice was determined at the same time each day. From
these data the mean survival time in days after transplantation of the tumour
was computed for each experimental group and its significance when compared
with the control group tested by t test.
In vitro procedures
Pooled Ehrlich ascites from several mice was preserved in small portions in a
freezing unit (- 30° C.). It was found, that the ability of this material to incor-
porate a labelled amino acid was not significantly decreased after 30 days of
preservation. For in vitro experiments, the ascitic fluid was quickly thawed by
immersinig in hot water, diluted with a solution of isotonic KCI and KHCO3
(1000: 8) till the protein content of the suspension was 0'5-0'7 per cent (the same
dilution being then used for the whole batch of Ehrlich ascites onI alternate days)
and. after addition of labelled amino acids and substances to be tested, immne-
diately incubated.
For some experiments, 5 per cent homogenates of liver and spleen tissue of
rats were prepared in a glass homogenizer. Animals were sacrificed by a blow oii
the head, tissues were immediately excised, minced with scissors, and homo-
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genized in an ice cold solution of isotonic KCI and KHCO3 in a Potter-Elvehjem
homogenizer cooled with ice cold water for 2-3 minutes.
DL-[35S]Methionine with an average activity of 0.6-07 mc per mg., was
obtained from the Radiological Research Institute in Prague. A solution of 1-5
mg. of the amino acid in 100 ml. of the above medium was used.
[Carboxy-14C]Glycine, with an activity of 0.16 mc per mg., was obtained from
the same source, was used in some experiments. A solution of 26 mg. of this
compound in 10 ml. ofincubation medium was used.
Compounds used in these experiments, except of those already stated, were
20-methylcholanthrene, pyrene, deoxycholic acid, and sodium glycocholate, all
of C.P. grade not further purified. Substances were finely homogenized in olive
oil and the resulting suspension or solution added to the incubation mixture.
Pure olive oil was given to control samples.
All control as well as experimental specimens were incubated in triplicate
samples. Each sample in a conventional Warburg flask containing 2 ml. ofdiluted
ascites tumour, or liver or spleen homogenate, 0.1 ml. of [35S]methionine or in
some instances glycine, and 0.1 ml. of olive oil or suspension of tested substance
was incubated with shaking in a Warburg apparatus at 37-5° C. for 45 minutes.
After this, duplicate samples (0.5 ml.) from each flask, were precipitated with
1 ml. of 20 per cent trichloroacetic acid. The precipitate was centrifuged after
10 minutes, homogenized in a glass homogenizer in 2 ml. of 5 per cent trichloro-
acetic acid, and centrifuged again. It was then successively washed in the same
way with another 2 ml. of 5 per cent trichloroacetic acid, hot (90° C.) 5 per cent
trichloroacetic acid (2 ml.), twice with 96 per cent ethanol (2 ml.) and once with
2 ml. ethanol-ether mixture (1: 1). The precipitate was then finely homogenized
in ether and samples for measurement for radioactivity were prepared on weighed
filter-paper discs. Details of this procedure as well as those used for radioactivity
assay are given in our recent paper (Hradec, 1958b).
Duplicate controls at zero time incubation were done with each series. Net
specific radioactivity obtained by subtracting the mean value of the control
sample from those incubated was taken into account in evaluation of the experi-
ments. Standard errors not exceeding i 3 per cent for duplicate samples of the
same flask and ± 5 per cent for average values from the same three specimens,
were found in the majority ofour experiments.
In the case of Ehrlich tumour, the actual specific radioactivities were 121-
243 counts/minute per mg. of dried protein precipitate in various batches of this
ascites tumour. When using the liver or spleen homogenate, actual specific acti-
vities were 25 to 42 counts/minute per mg. of dried protein precipitate. Samples
weighing 1.8-3.6 mg. were usually counted.
In some of our experiments the method of Melchior and Halikis (1952) was
used for the isolation of proteins for radioactivity assay to exclude the possible
occlusion of radioactivity on protein precipitates which might cause some sources
of errors in our original method.
RESULTS
Effect ofpolycyclic hydrocarbons and related compounds on the survival rate of mice
bearing the Ehrlich carcinoma
The growth of Ehrlich ascites carcinoma in mice after administration of
various compounds tested is given in Table I.GROWTH OF EHRLICH ASCITES CARCINOMA
TABLE I.-Effect ofCarcinogenic Hydrocarbons and Related Compounds on the
Survival Rate of Mice Bearing the Ehrlich Ascites Carcinoma
Dose (10-n mg.)
A
Compound
3,4-benzopyrene
1,2,5,6-dibenzan-
thracene
Anthracene
Phenanthrene .
Chrysene
Cholesterol
Dehydrocholic acid .
;Survlval r
time 0 1 2 3 4 5 6 7 8 C
· mean .14-9 16-3 15-5 16-1 15-5 13-8 12-5 12.9 13-3 14-1
ranges .12-18 11-20 12-19 13-19 13-17 10-18 10-15 9-15 11-16 12-19
S . 2-18 2.88 2-16 1.75 1.17 1.58 1.14 1.48 1-26 2.07
P . 0-2 0.01 0-01 0.01 0.01 0-1 0.01 0.01 0-01 -
mean .14-0 13- 3 13-9 12-8 12-4 13-2 13-6
ranges .12-17 10-15 10-17 10-16 10-15 10-15 9-18 -
S 1-34 1-17 1-76 1-16 1.42 1-34 2-18 -
P . 0-01 - 0-1 005 0.01 - 0-2 -
. mean .14-9 15-3 16-4 15-3 12-9 13-7 14.2 14-4
ranges .11-17 10-18 12-21 13-17 10-15 12-19 12-20 11-17
S . 1-25 1-78 2.86 1-29 1-22 1-57 1-47 1-62
P 0.1 0-02 0-01 0.01 0-01 0-05 - -
mean .14-5 14-1 13-7 14-5 14.4 14-0 14-1
ranges .14-20 10-17 12-17 8-17 8-18 9-17 8-18 -
S . 2-64 2-12 1-60 2-31 2-25 1-96 2-16 -
P .. . .
- 13-2
- 10-15
- 1*22
14-3 14-1
11-17 12-19
1-84 2 07
- 14-3
9-17
1-84
. mean .11-8 12-4 12-5 11-8 12.3 13-1 12-0 12-7 12-0 14-3
ranges . 7-14 7-14 7-16 10-13 8-14 11-14 10-14 9-15 11-14 10-16
S . 1-79 1-78 2-06 0.30 1-67 0-28 1-27 1-63 0-31 1-96
P . 0-01 0.01 0-01 0-01 0.01 0-01 0.01 0.01 0.01 -
. mean .11-8 13-1 12-6 12-2 12.6 12-8 13-2 -
ranges . 9-15 9-20 9-19 8-18 9-17 9-20 10-19 -
S . 1-67 2-88 2-87 2-78 2-64 2-88 2-68 -
P . 0.05 - 0-8 0'3 - - - -
13-1
10-20
2-90
mean .15-1 15-1 15-4 16-1 14.3 14.0 12-0 11-8 11-8 13.5
ranges .10-17 11-17 13-18 9-18 9-16 9-16 9-16 9-15 9-17 9-16
S . 2-00 2-19 0-32 2-17 1.95 2-27 2-40 2-34 2-11 1-93
P . 0.01 0.01 0.01 0.01 0.2 0.4 0.05 0.01 0-01 -
All values are given in days after the transplanatation of the Ehrlich tumour.
C -= control group.
S = standard deviation.
Phenanthrene in dose levels 1-0-000001 mg. proved ofno effect on the survival
time of mice with the tumour. Little effect was also observed when cholesterol
was used. Only the highest dose, i.e. 1 mg., caused a slight enhancement of the
tumour growth.
A marked change in the survival rate oftumour-bearing mice was found after
the administration of both strong carcinogenic agents, benzopyrene and dibenz-
anthracene. High doses of these substances seem generally to possess an inhi-
biting effect while trace doses of them caused a marked acceleration in tumour
growth. The highest dose used, i.e. 1 mg., proved to be ineffective in the case of
benzopyrene while the next lower dose reduced significantly the growth rate of
the tumour. Trace doses of this compound exhibit a pronounced suppressing
effect on the survival time of animals bearing the Ehrlich tumour. Very similar
effects were seen when dibenzanthracene was used. Higher doses ofthis substance,
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however, seem to be necessary forthe inihibition as well as stimulation ofthe tumour
growth as if the same pattern ofeffectiveness were being postponed to higher dose
levels.
Unexpectedly, the same general pattern was found when the non-carcinogenic
anthracene was used. There seems to be only one difference when compared with
the effect of carcinogenic hydrocarbons. Intermediate doses which are without
effect are not found between inhibitory dose levels and those which enhance.
The amount of this compound necessary for increasing the mean survival time of
100
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E
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FIG. 1.-MAortality of Imice administered 0'001 mg. dehydrocholic acid (dashed line) when comnpared
with that of controls (full line).
animals corresponds roughly to that of benzopyrene while higher doses are
required for enhancement of tumour growth.
Similar effects to those obtained in the case of carcinogenic hydrocarbons and
anthracene are also found when dehydrocholic acid is used. There was. however,
a unique position ofthis substance among all other compounds tested. High doses
increasing the mean survival time of tumour-bearing mice had a much more
pronounced effect than carcinogenic hydrocarbons in the same doses. In many
groups receiving these doses of dehydrocholic acid all animals were living at the
time when all controls had died, as is seen in Fig. 1.
In other respects, however, there is little difference when using this compound
or benzopyrene. The same trace doses enhance the tumour growth, these being
separated by ineffective doses from those which inhibit.
A striking effect was observed when chrysene was used. This compound was
the only one of all substances tested which caused an enhancement of tumour
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growth in all doses used, the same effect being observed after administration of
1 mg. of this substance as in the case of 0.00001 ,tg.
Effect of polycyclic hydrocarbons and related compounds on the incorporation of
labelled amino acids into proteins
Incorporation of [35S]methionine into the proteins ofEhrlich ascites carcinoma
in vitro is affected by the addition of some polycyclic hydrocarbons or related
compounds to the incubation mixture, as is seen from Table II.
TABLE II.-EffectofChemical Carcinogens and Related Compounds on the Incorpora-
tion of [35S]Methionine into the Proteins of Ehrlich Ascites Carcinoma In Vitro
(given as per cent of stimulation or inhibition if control specimen's value is equal
to 100 per cent)
Dose (10-n mg.)
Compound
0 1 2 3 4 5 6 7 8
Benzopyrene . . -66 -22 -17 +23 0 0 - 6 +72 +27
Dibenzanthracene . . - 7 -24 +41 +140 +91 +164 -63 + 3 - 7
Methylcholanthrene . . +67 +38 +41 +98 +46 +123 +28 -23 0
Anthracene +22 +23 +18 +20 +19 +23 + 1 0 0
Phenanthrene . . -24 -18 -16 -13 -11 - 8 0 0 0
Pyrene . 57 -36 -31 -20 -19 -19 0 0 0
Chrysene -10 -17 -17 +25 +30 +22 -12 -22 -15
Cholesterol . . -24 -19 -20 -22 -14 -10 - 6 0 0
Deoxycholic acid . -61 -24 -25 + 8 +23 +15 -14 0 0
Dehydrocho]ic acid . -67 -38 -22 -15 -14 -11 -11 0 0
Sodium glycocholate . . -19 -16 -14 - 8 - 5 0 0 0 0
Carcinogenic substances seem to be able to effect the incorporation of labelled
methionine in both directions-some doses of them inhibit this process partially
while others stimulate it. This effect is very clearly seen especially when strong
carcinogenic hydrocarbons, i.e. benzopyrene, dibenzanthracene, or methylchol-
anthrene, were added to the incubation medium. The general dose-response
pattern is very similar in all these compounds. It consists of two well defined
doses of maximal stimulating effect. The first of them, common for all three
compounds tested, is 1 /ug., while the other, for dibenzanthracene and methyl-
cholanthrene only, seems to be 0.01/tg. This second effective dose is also present
in the case of benzpyrene, here it lies, however, in significantly lower dose levels,
i.e. 0.0001 /ug. On the contrary, such well defined doses of maximal inhibitory
effect are not found when carcinogenic compounds are used. High doses of benzo-
pyrene and dibenzanthracene depressed the incorporation of labelled methionine
into the proteins of Ehrlich ascites carcinoma at a dose of 1 or 0.1 mg.; no
similar effect was found, however, when methylcholanthrene was used. On the
contrary, high doses of this compound stimulate this process to a considerable
extent. It cannot be excluded, however, that even higher doses than those used
would be necessary to exhibit the depressing effect of methylcholanthrene.
Trace doses lower than those showing the second stimulation maximum, seem
also to be capable of inhibiting partially the incorporation of labelled methionine
into proteins. This is seen in the case ofdibenzanthracene and methylcholanthrene
in dose levels of 0.001 and 0.0001/tg., respectively. The same inhibiting dose was
found in the case of benzopyrene. Doses of highest stimulating effect are sepa-J. HRADEC
rated by dose levels with somewhat lower stimulating activity or none at all (as
in the case of benzpyrene).
A different pattern was found when weak carcinogenic substances, chrysene
and deoxycholic acid, were used instead of the strongly carcinogenic ones. A
similar general dose response is seen, some doses exhibiting a depressing while
others a stimulating effect. Only one highest effective dose is demonstrable, how-
ever, in this case. It seems to be the same with both substances tested, i.e. 0.1 ,ug.
It is definitely different from both maximally effective doses found when strong
carcinogens were used. Two suppressing dose levels were observed, the first in
high doses while the other in lower ones. Similarly, as in the case of strong carci-
nogens, trace doses have an inhibiting activity when using weak carcinogens. It
seems necessary, however, for these doses to be somewhat higher than in the case
ofstrong carcinogens.
Non-carcinogenic hydrocarbons, cholesterol, and some bile acids, with the
exception only of anthracene, had no stimulating effect on the incorporation of
labelled methionine into the proteins of Ehrlich ascites carcinoma. High doses
of these compounds have a definite inhibiting effect on this process, this effect
gradually diminishing when lower doses are used.
Anthracene possesses a unique position in the whole group of substances
tested. The addition of this compound to the incubation mixture markedly
stimulates the incorporation. No alternate stimulating and inhibiting effect is
demonstrable, however, as in the case of carcinogens; this action seems to be
largely dose-independent, and the same effect is seen at various dose levels from
1 mg. to 001jtg.
Since high blank values (10-15 per cent of the incubated samples values)
were found when using our original method of preparing protein samples for
radioactivity assay it was necessary to exclude the possible effect of occlusion of
radioactivity on the protein precipitates. For this reason the method of Melchior
and Halikis (1952) was used in several experiments to exclude this possible source
of error. A triplicate precipitation and solution of the precipitated protein effec-
tively removed essentially all the adsorbed radioactivity and no activity was
found in zero time controls. The results of experiments performed in this way
agreed strictly with those obtained by our original method.
In some of our experiments glycine was used instead of methionine as the
labelled amino acid. Closely related results to those obtained with methionine
were encountered. This is clearly shown in Fig. 2, where a very similar effect is
seen of 3,4-benzopyrene on the incorporation of [35S]methionine and [14C]glycine,
respectively, into the proteins of Ehrlich ascites carcinoma.
When the incorporation of labelled methionine into the proteins of liver and
spleen homogenate was studied, a very low activity of this process, only 10-20
per cent of that in Ehrlich carcinoma, was found the zero time controls having
60-65 per cent of the radioactivity of incubated samples. Since the zero time
controls were very high in these cases, some doubt could be thrown on the signifi-
cance of these results. For this reason, several experiments were made in the same
way and a statistical treatment of their results was performed by means of t test.
Highly significant differences were found between various dose levels. The effect
ofvarious doses of 1,2,5,6-dibenzanthracene on the incorporation oflabelled methi-
onine into the proteins of liver and spleen homogenate is given in Fig. 3. This
figurerepresents average valuesof5 experimentsdone on the same sortofmaterial.
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FIG. 2.-Effect ofvarious doses of3,4-benzopyrene on the incorporation of[35S]methionine (fullline) and [14C]glycine (dashed line) into the proteins of Ehrlich carcinoma.
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FIG. 3.-Effect of various doses of 1,2,5,6-dibenzanthracene on the incorporation of [35S]methionine
into the proteins of liver (full line) and spleen homogenate (dashed line).
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When liver homogenate is used, the same general pattern as in the case of
Ehrlich ascites carcinoma is obtained. Two doses causing maximum ofstimulation
are again separated by a less active dose. The second maximally effective dose
corresponds well with that described in the case of Ehrlich carcinoma, the first
being postponed to higher dose levels. An inhibiting dose could be demonstrated
in very low dose levels again closely resembling the results obtained with the
tumour.
A clearly different pattern, however, was observed when spleen homogenate
was used. The general dose-dependent effect is visible in this case, too, some doses
having a stimulating while others an inhibiting effect on the incorporation of
labelled methionine into proteins. Only one dose showed a stimulating activity,
this being distinctly lower, however, than in the case of liver or tumour tissue.
The majority ofdoses inhibited the incorporation oflabelled methionine.
DISCUSSION
Our results clearly demonstrate that higher doses of strongly carcinogenic
hydrocarbons show an inhibiting effect on the growth of Ehrlich carcinoma while
smaller doses have a quite diverse activity. The diversity ofresults ofthe previous
authors mentioned already can therefore be explained on the basis of different
doses used in their experiments. This changing ofstimulating and inhibiting effect
is not specific, however, for carcinogenic hydrocarbons, the same activity being
demonstrable for instance in the case ofnon-carcinogenic anthracene and dehydro-
cholic acid. Thus no real correlation between carcinogenity and the effect oftested
compounds on the survival rate oftumour-bearing mice is seen in our experiments.
A similar dose-dependent effect was also seen in our recent experiments, when
homogenates of various tissues from tumour-bearing animals were administered
to rats before the transplantation of Walker 256 carcinoma took place (Hradec.
Dusek, Trojan and Ptacek, 1958). The presence of a similar substance in these
tissues can be assumed on the basis of these experiments. Such a compound has
since been isolated from this material (Hradec, 1958c).
A very interesting effect was exhibited by chrysene which is known to be a
weak carcinogen (Hartwell, 1951).
Our method used for measuring the growth of Ehrlich ascites tumour by
survival time of the animals is of course only an indirect criterion for this process
(Klein and R6v6sz, 1953). There seems to be no strict correlation between the
number of tumour cells and the survival rate of the mice bearing ascites tumours
(Patt and Blackford, 1954). On the other hand, the same material was used for
the transplantation of all experimental as well as control animals and statistically
significant differences in the survival time were found in many instances. It
cannot be excluded, however, that some conditioning of the animals occurred
due to the action of tested compounds resulting in prolongation of their lives,
the actual tumour growth being not affected. This possibility, nevertheless, seems
not to be very probable, since cell counts and measurements of the amount of
ascites fluid made occasionally in all groups of animals showed no correlation
between the cell counts and time ofdeath.
Some similarities are found when comparing the results of our in vivo experi-
ments with those obtained in vitro. A common general pattern is seen in many
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instances. Substances stimulating the incorporation of labelled amino acids into
proteins invariably enhance the growth of the Ehrlich tumour in vivo. Moreover,
higher doses of carcinogenic hydrocarbons show an inhibitory activity in both
in vivo and in vitro, trace doses of these substances being active in the inverse
sense. Only in the case of anthracene was this proved not to be so. While in vivo
results show a close correlation with those obtained when testing strong carcino-
gens, the effect in vitro was always to stimulate the incorporation of labelled
amino acid, no dose showing an inhibitory activity comparable with that demon-
strable in vivo. Another discrepancy between in vivo and in vitro patterns is found
in the case of chrysene. An overall enhancing effect on the growth rate of the
Ehrlich carcinoma is dissimilar to the dose-dependent inhibiting or stimulating
activity obtained in vitro.
A good correlation between the results of both procedures is seen when using
cholesterol. Dehydrocholic acid-the most active substance in depressing the
incorporation in vitro of all substances tested in our experiments-prolongs
significantly the survival of mice bearing the Ehrlich tumour.
Since [35S]methionine was used in our experiments it is not posssible to con-
clude that incorporation of radioactivity into protein was necessarily due to a
peptide linkage of methionine. For example cystine can be formed from methio-
nine during the incubation and this could be incorporated into the protein
(Melchior and Tarver, 1947). Our results, however, cannot merely be due to the
effect of various substances on the rate of formation of such disulphide bonds in
proteins since the same results were found when [14C]glycine was used. No other
types of bonds than peptide can be assumed when this amino acid is used and it
seems quite reasonable to suppose on the basis of our experiments that the tested
compounds affect the growth rate of tumours by acting on the biosynthesis of
proteins. Additional mechanisms are without doubt involved in the processes as
can be assumed from some discrepancy between the in vivo and in vitro results.
In contrast to the results obtained in vivo, the effect of various compounds in
vitro is quite consistent with their carcinogenic activity. There seems to be a
pattern characteristic for carcinogenic substances as well as for the non-carcino-
gens. The stimulating activity alone, however, seems to be not specific for carci-
nogenic substances, as the same effect is seen in the case of the non-carcinogenic
anthracene. The alternating enhancing and inhibitory effect, however, is demon-
strable only when carcinogens are used. In the case of strongly carcinogenic
hydrocarbons-benzopyrene, dibenzanthracene, and methylcholanthrene-two
definite doses of maximal stimulating activity are seen with a dose of significantly
lower enhancing effect lying between both of them. In the case of weak carcino-
gens, chrysene and deoxycholic acid (Schabad, 1945), only one dose of highest
activity was shown. The inhibitory effect ofvery high as well as ofvery low doses,
the same as with strong carcinogens, is demonstrable. Although in explaining the
inhibitory activity ofthe high doses some unspecific mechanisms must be without
doubt taken in account, the inhibitory effect of trace doses seems to be specific
for this group of substances.
Non-carcinogenic substances showed in high doses an inhibitory effect on the
incorporation of labelled methionine or glycine into proteins, this effect gradually
diminishing with the dose used, the smallest doses being without effect.
A unique position in the group of non-carcinogenic substances tested is held
by anthracene. Only this compound showed a small, nevertheless significant,
24
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stimulating activity in high doses in vitro. It is not possible so far to explain this
fact until the mechanism of this stimulating effect is further elucidated.
Three specific patterns therefore seem to be demonstrable when strong carci-
nogens, weak carcinogens, and non-carcinogenic compounds are tested, as given
in Fig. 4.
The study of the effect of carcinogenic substances on the metabolism of pro-
teins seems to be a new, promising approach to the research on the mode ofaction
of these compounds. It will be necessary to make clear the mechanism of this
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FIG. 4.-General dose response pattern for strong carcinogenic substances (1,2,5,6-dibenzanthracene,
full line), weak carcinogens (chrysene, dashed line), and non-carcinogenic compounds (chole-
sterol, dotted line).
process. It cannot be assumed from our present experiments that an increase in
the net-synthesis of proteins is necessarily caused by the action of carcinogens
since a mere study of incorporation of a labelled amino acid into proteins cannot
solve this problem (Borsook, 1954). It cannot be excluded, for instance, that an
inhibition of proteolytic processes claimed by some authors (Rondoni, 1955) is
involved in this effect. These and some further aspects are being studied in detail
in our laboratory to make clearer relations between protein metabolism and the
action of chemical carcinogens.
SUMMARY
1. Suspensions of benzopyrene, dibenzanthracene, anthracene, phenanthrene,
chrysene, cholesterol, and dehydrocholic acid in olive oil were administered in
1 mg. to 10-8 mg. doses to mice on the day preceding the intraperitoneal trans-
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planatation of Ehrlich ascites carcinoma and the survival time in individual
groups statistically evaluated.
2. The effect of olive oil suspensions of the above substances as well as that of
methylcholanthrene, pyrene, deoxycholic acid, and sodium glycocholate in 1 mg.
to 10-8 mg. doses on the incorporation of [35S]methionine or [14C]glycine into
the proteins of Ehrlich ascites carcinoma and liver or spleen homogenate was
tested.
3. Benzopyrene, dibenzanthracene, anthracene, and dehydrocholic acid in high
doses reduces the tumour growth while in smallest doses they enhance this process.
Chrysene stimulates the growth in all doses used while phenanthrene and chole-
sterol are without effect.
4. A specific effect on the incorporation of labelled amino acids into proteins
was found with strong carcinogens, weak carcinogens and non-carcinogenic
substances. Some doses of carcinogens stimulate this process while others inhibit
it. One dose of maximal stimulating effect was found when using weak carci-
nogens while two such peaks were exhibited by strong carcinogens. Only an
inhibitory effect was seen when highest doses of non-carcinogenic compounds
were added, with the exception of anthracene in which a slight stimulating effect
was caused by some of the highest doses.
5. Relations between the effect on protein synthesis and that on the tumour
growth are discussed and the importance of protein synthesis affecting activity
of carcinogenic substances is indicated.
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